Real-world data’s power to increase racial diversity in clinical research

Real-world data has come into focus as one of the most important resources for accelerating drug development and defining the natural history of the disease during the pandemic, but it also represents one of the best tools available for addressing racial disparity in clinical research.

FDA has issued guidances and plans of action to address the issue over the past decade, but the lack of diversity in clinical trials remains a glaring problem across the biopharma industry. And Black patients are particularly underrepresented...